- Home
- PMVP vs IHD Comparison
PMVP vs IHD Comparison
Compare PMVP & IHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMVP
- IHD
- Stock Information
- Founded
- PMVP 2013
- IHD 2011
- Country
- PMVP United States
- IHD United States
- Employees
- PMVP N/A
- IHD N/A
- Industry
- PMVP Medicinal Chemicals and Botanical Products
- IHD Investment Managers
- Sector
- PMVP Health Care
- IHD Finance
- Exchange
- PMVP Nasdaq
- IHD Nasdaq
- Market Cap
- PMVP 55.1M
- IHD 94.9M
- IPO Year
- PMVP 2020
- IHD N/A
- Fundamental
- Price
- PMVP $1.25
- IHD $5.84
- Analyst Decision
- PMVP Strong Buy
- IHD
- Analyst Count
- PMVP 1
- IHD 0
- Target Price
- PMVP $5.00
- IHD N/A
- AVG Volume (30 Days)
- PMVP 230.0K
- IHD 27.7K
- Earning Date
- PMVP 08-07-2025
- IHD 01-01-0001
- Dividend Yield
- PMVP N/A
- IHD 10.32%
- EPS Growth
- PMVP N/A
- IHD N/A
- EPS
- PMVP N/A
- IHD N/A
- Revenue
- PMVP N/A
- IHD N/A
- Revenue This Year
- PMVP N/A
- IHD N/A
- Revenue Next Year
- PMVP N/A
- IHD N/A
- P/E Ratio
- PMVP N/A
- IHD N/A
- Revenue Growth
- PMVP N/A
- IHD N/A
- 52 Week Low
- PMVP $0.81
- IHD $4.49
- 52 Week High
- PMVP $1.82
- IHD $5.47
- Technical
- Relative Strength Index (RSI)
- PMVP 64.21
- IHD 55.35
- Support Level
- PMVP $0.96
- IHD $5.77
- Resistance Level
- PMVP $1.36
- IHD $5.93
- Average True Range (ATR)
- PMVP 0.09
- IHD 0.06
- MACD
- PMVP 0.01
- IHD -0.02
- Stochastic Oscillator
- PMVP 72.22
- IHD 55.17
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
About IHD Voya Emerging Markets High Income Dividend Equity Fund
Voya Emerging Markets High Dividend Equity Fund is a diversified closed-end management investment company. Its primary investment objective is to provide total return through a combination of current income, capital gains, and capital appreciation. The company seeks to achieve its investment objectives by investing principally in a portfolio of equity securities, and issuers in emerging market countries. The Fund will also normally seek to secure gains and enhance the stability of returns over a market cycle by writing (selling) call options on selected exchange-traded funds (ETFs) and/or international, regional, or country indices of equity securities, and/or on equity securities.